$ARCC

ARES CAPITAL CORPORATION SCHEDULES EARNINGS RELEASE FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2026

Ares Capital (ARCC) will release Q3 2026 earnings on Oct 27, 2026. A conference call is scheduled for the same day. The company is a leading BDC focused on middle-market loans. It is managed by Ares Management (ARES).

Original reporting
Published Oct 2, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ARES CAPITAL CORPORATION SCHEDULES EARNINGS RELEASE FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2026 — source image
Decision brief

The 30-second read

$ARCCNeutralMed
01

Why it matters

The release date announcement provides a clear timeline for analysts and traders to align their models and trade strategies around the upcoming earnings call.

02

Market read

The news is primarily relevant to investors in ARCC and BDC‑focused funds; it has minimal impact on broader markets.

03

What to watch

Potential impact of macro‑economic conditions on the BDC's loan portfolio may become relevant when the results are released.

Relevance 6/10Novelty 6/10Timing: pre‑market on Oct 27 2026

Background

Ares Capital is the largest publicly traded business development company (BDC) in the US, regularly reporting quarterly results.

Company-level read

Ticker impact

$ARCCNeutralHigh confidence
Context

Ares Capital announced the date and time of its Q3 2026 earnings release and webcast.

Expected impact

limited short‑term movement as traders position ahead of the release; no immediate directional bias.

Evidence & confidence

Earnings release dates are routine but provide a concrete timing cue; no new guidance or material numbers were disclosed.

Market effects

None beyond the BDC sector; the schedule does not alter sector fundamentals.

US‑focused; no broader regional effect.

Limited to investors tracking BDC earnings calendars.

Counterpoint

If the market expects a surprise in the upcoming earnings, the schedule could be a catalyst for speculative positioning.

Key entities

  • Ares Capital Corporation

    Specialty finance BDC that provides direct loans to middle‑market companies.

Related articles

$ARCCMed

Ares Leads $2.2 Billion Healthcare Loan

Ares Management Corp. is leading a $2.2 billion loan to MedImpact Holding Inc. to finance its acquisition of Medical Card System, Inc. The second-lien loan may pay at least 8% over the baseline rate. Ares manages $671 billion in assets and recently reported $708 billion in non-accruing loans. MedImpact serves 20 million customers and processes $40 billion in pharmacy transactions annually.

$ARCCMed

Ares Capital Q2 Earnings Call Highlights

Management expects industry credit conditions to continue normalizing toward longer-term averages, though it said performance differences among managers have widened. Schnabel said Ares Capital added four investments to non-accrual during the quarter, but the companies were in unrelated businesses and did not indicate a sector-specific trend.